Search
Displaying results 71 to 80 out of 2,742
-
Rapid Assessment on Policy and Operational Barriers to the Integration of FP/RH/HIV Services in Kenya
rhsupplies.org/uploads/tx_rhscpublications/725_1_Kenya_Barr…
-
WOMEN HIV AND THEIR SEXUAL AND REPRODUCTIVE HEALTH RIGHTS
rhsupplies.org/uploads/tx_rhscpublications/WOMEN__HIV_AND_T…
-
PowerPoint Presentation
rhsupplies.org/fileadmin/uploads/rhsc/Uploads/Other/2022.05…
Translating science into global health impact bnAbs for HIV prevention Shelly Malhotra NURHT Caucus Webinar May 9, 2022 3 Contents The burden of HIV The case for bnAbs Global Access HIV An Unmet Need • The HIV pandemic continues to cause extensive morbidity and mortality globally and is a top public health priority • Despite progress in reaching 73% of people living with HIV with antiretroviral therapy, gaps in HIV prevention and treatment contributed to 1.5 million new infections and 680,000 HIV-related deaths in 2020 • Adolescent girls and young women (AGYW) in low- and middle-income…
-
Global Fund approves FP commodities for Uganda
Home › News & Events › Global Fund approves FP commodities for Uganda
for the prevention of unintended pregnancies among HIV infected individuals. The target is to increase uptake of family planning (FP) among men and women living with HIV from 24% to 60% (assuming that uptake among HIV infected individuals is the same as the general population). Inclusion of commodities resulted from a strong proposal, informed by Coalition member Advance Family Planning (AFP) and its partners. AFP…
-
PowerPoint Presentation
rhsupplies.org/fileadmin/uploads/rhsc/General_Membership_Me…
MPH IMPT | CAMI Health 3 Women’s Sexual & Reproductive Health Risks are Interlinked Women need better protection Unintended Pregnancy HIV Other Sexually Transmitted Infections (STIs) 4 HIV, HSV-2, HPV, and Unmet Need for Modern Contraception among Women Source: Schelar, et al. http://www.contraceptionjournal.org/article/S0010-7824%2815%2900577-6/ 5 Multipurpose Prevention Technologies (MPTs) MPTs combine protection against: • Unintended pregnancy • HIV • Other STIs 6 A Suite of Products is Needed Contraception + HIV Prevention Contraception + STI Prevention HIV +…
-
Slide 1
rhsupplies.org/fileadmin/uploads/rhsc/General_Membership_Me…
HIV continues to be a major global public health issue, having claimed more than 35 million lives so far. In 2016, 1.0 million people died from HIV-related causes globally. There were approximately 36.7 million people living with HIV at the end of 2016 with 1.8 million people becoming newly infected in 2016 globally. The Status of AIDS Three randomized controlled trials in Africa (2003 to2006) •South Africa 76% •Kenya 60% •Uganda 55% Male circumcision significantly reduces the risk of HIV infection>60% Reduce HIV infection approximately 60% Reduce HPV infection 32%-35% Reduce HSV-2…
-
compar report.indb
rhsupplies.org/uploads/tx_rhscpublications/DOC49-1-1.pdf
Sex education Summary of findings HIV/AIDS Knowledge of gonorrhea and syphilis Knowledge of HIV/AIDS Means of preventing the transmission of HIV/AIDS Knowledge and use of the test to detect HIV…
-
06 czh029 (jr/d)
rhsupplies.org/uploads/tx_rhscpublications/(medical journal…
To provide programme managers and decision- makers with a guide to costing in HIV/AIDS, we review the best resources in this area. A cost analysis identifies all inputs or resources that a programme uses and their costs. A cost-effectiveness analysis goes one step further, measuring the impact a programme has on the HIV/AIDS epidemic relative to its cost (see HIV InSite website). Programme planners can use these findings to make informed decisions about how and where to channel resources. For detailed information on costing methodology, we recommend Costing guidelines for HIV prevention strategies (Kumaranayake et…
-
Family Health Intl- Quick reference chart for the WHO Medical Eligibility Criteria for Contraceptive Use
Home › Activities & Resources › Family Health Intl- Quick reference chart for the WHO Medical Eligibility Criteria for Contraceptive Use
pelvic inflammatory disease (PID) I C Other STIs (excluding HIV/hepatitis) Increased risk of STIs Very high individual risk of exposure to STIs I C HIV High risk of HIV or HIV-infected AIDS…
-
Quick Reference Chart for the Medical Eligibility Criteria of the WHO
rhsupplies.org/uploads/tx_rhscpublications/Family Care Intl…
Hepatitis Active Client is a carrier Liver tumors STIs/PID Current purulent cervicitis, chlamydia, gonorrhea I C Vaginitis Current pelvic inflammatory disease (PID) I C Other STIs (excluding HIV/hepatitis) Increased risk of STIs Very high individual risk of exposure to STIs I C HIV High risk of HIV or HIV-infected AIDS No antiretroviral therapy (ARV) I C Not clinically well on ARV therapy I C Clinically well…